PACIRA BIOSCIENCES, INC. Inventory
PACIRA BIOSCIENCES, INC. (PCRX) had Inventory of $134.57 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-04
- 2026-06-30: Inventory, Net $134.57M.
- 2026-03-31: Inventory, Net $150.37M.
- 2025-12-31: Inventory, Net $152.86M.
- 2025-09-30: Inventory, Net $157.68M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $134.57M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $150.37M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $152.86M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $157.68M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $148.16M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $133.75M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $125.28M 10-K · filed 2026-02-26 |
| 2024-09-30 | $111.86M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $103.44M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $96.78M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $104.35M 10-K · filed 2025-02-27 |
| 2023-09-30 | $96.52M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $92.13M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $92.98M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $96.06M 10-K · filed 2024-02-29 |
| 2022-09-30 | $96.80M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $100.59M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $103.66M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $98.55M 10-K · filed 2023-02-28 |
| 2021-09-30 | $67.21M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $65.26M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $64.61M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $64.65M 10-K · filed 2022-02-28 |
| 2020-09-30 | $68.54M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $66.69M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $59.67M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $58.30M 10-K · filed 2021-03-01 |
| 2019-09-30 | $60.24M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $52.70M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $47.03M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $48.57M 10-K · filed 2020-02-21 |
| 2018-09-30 | $44.88M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $42.05M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $40.04M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $41.41M 10-K · filed 2019-02-28 |
| 2017-09-30 | $39.11M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $33.60M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $30.31M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $31.28M 10-K · filed 2018-02-28 |
| 2016-09-30 | $37.48M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $60.92M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $63.74M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $61.65M 10-K · filed 2017-03-01 |
| 2015-09-30 | $56.13M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $48.77M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $36.26M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $29.26M 10-K · filed 2016-02-25 |
| 2014-09-30 | $23.66M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $19.19M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $15.36M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $15.56M 10-K · filed 2015-02-24 |
| 2013-09-30 | $15.61M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $14.22M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $10.76M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $12.08M 10-K · filed 2014-02-25 |
| 2012-09-30 | $11.91M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $9.30M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $5.08M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $1.25M 10-K · filed 2013-03-07 |
| 2011-09-30 | $1.67M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $1.88M 10-Q · filed 2011-08-11 |
| 2010-12-31 | $1.60M 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |